Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer

Cancer Gene Therapy volume 25, pages 39–46 (2018)Cite this article

Subjects

Abstract

Long non-coding RNAs (lncRNAs) have been demonstrated to be critical regulators in tumorigenesis. LncRNA SPRY4-IT1 has been identified as critical regulator for hepatocellular carcinoma and ovarian cancer. However, the potential role and clinical value of SPRY4-IT1 in human thyroid cancer (TC) still remain unclear and need to be uncovered. Our current study was aimed to ascertain the biological role of expression of SPRY4-IT1 in TC tissues and cells. Our findings revealed that the level of SPRY4-IT1 was significantly upregulated in TC tissues and cell lines, which was correlated with poor prognosis. And cellular experiments exhibited that silenced SPRY4-IT1 inhibited the proliferative and migratory abilities of TC cells. Mechanism assays noted that silenced SPRY4-IT1 could increase the levels of transforming growth factor-β1 (TGF-β1) and p-Smad2/3 and function mediated by si-SPRY4-IT1 could be rescued by the interference of TGF-β1. Generally speaking, these findings elucidated that SPRY4-IT1 might become a novel prognostic factor in the clinical behaviors of TC patients and participated in the progression of TC through targeting TGF-β/Smad signaling pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012; 380:2095–128.

  3. Vigneri R, Malandrino P, Vigneri P. The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin Oncol. 2015;27:1–7.

    Article  PubMed  Google Scholar 

  4. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 2012;31:4577–87.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Malakar P, Shilo A, Mogilavsky A, Stein I, Pikarsky E, Nevo Y, Benyamini H, Elgavish S, Zong X, Prasanth KV and Karni R. Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation. Cancer Res. 2016;77:1155-1167.

  6. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai M-C, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071–148.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Zhang Y, Sun L, Xuan L, Pan Z, Li K, Liu S, Huang Y, Zhao X, Huang L, Wang Z, Hou Y, Li J, Tian Y, Yu J, Han H, Liu Y, et al. Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction. Sci Rep. 2016;6:22384.

  8. Zhang G, Wu Y, Xu D, Yan X, Long noncoding RNA UFC1 promotes proliferation of chondrocyte in osteoarthritis by acting as a sponge for miR-34a. DNA Cell Biol. 2016;35:691–95

    Article  PubMed  CAS  Google Scholar 

  9. Fernandez-Barrena MG, Perugorria MJ and Banales JM. Novel lncRNA T-UCR as a potential downstream driver of the Wnt/beta-catenin pathway in hepatobiliary carcinogenesis. Gut. 2016;35:691-695.

  10. Cao Y, Xu R, Xu X, Zhou Y, Cui L, He X. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells. Mol Med Rep. 2016;14:1019–25.

    Article  PubMed  CAS  Google Scholar 

  11. Zhou M, Zhang XY, Yu X. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Biomed Pharmacother. 2017;85:348–54.

    Article  PubMed  CAS  Google Scholar 

  12. Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget 2017;8:3104–10.

    PubMed  Google Scholar 

  13. Tan W, Song ZZ, Xu Q, Qu X, Li Z, Wang Y, Yu Q, Wang S. Up-regulated expression of SPRY4-IT1 predicts poor prognosis in colorectal cancer. Med Sci Monitor 2017;23:309–14.

    Article  CAS  Google Scholar 

  14. Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X, Wang M, Huang C, Wang L, Zeng F, Jiang G. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. Cancer Lett. 2017;388:281–91.

    Article  PubMed  CAS  Google Scholar 

  15. Li N, Tan Q, Jing W, Luo P and Tu J. Long non-coding RNA SPRY4-IT1 can predict unfavorable prognosis and lymph node metastasis: a meta-analysis. Pathol Oncol Res. POR. 2017;23:731–736.

  16. Li H, Liu C, Lu Z, Chen L, Wang J, Li Y, Ma H. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer. Biomed Pharmacother. 2017;88:529–34.

    Article  PubMed  CAS  Google Scholar 

  17. Zuo Q, Huang S, Zou Y, Xu Y, Jiang Z, Zou S, Xu H, Sun L. The Lnc RNA SPRY4-IT1 modulates trophoblast cell invasion and migration by affecting the epithelial-mesenchymal transition. Sci Rep. 2016;6:37183.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Xu J, Ding R, Xu Y. Effects of long non-coding RNA SPRY4-IT1 on osteosarcoma cell biological behavior. Am J Transl Res. 2016;8:5330–37.

    PubMed  PubMed Central  CAS  Google Scholar 

  19. Zhao JJ, Hao S, Wang LL, Hu CY, Zhang S, Guo LJ, Zhang G, Gao B, Jiang Y, Tian WG, Luo DL. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-beta/Smad signaling pathway. Oncotarget 2016;7:57903–18.

    PubMed  PubMed Central  Google Scholar 

  20. Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, Zhang Q, Yan G, Cui Q. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 2013;41(D1):D983–6.

    Article  PubMed  CAS  Google Scholar 

  21. Li T, Yang XD, Ye CX, Shen ZL, Yang Y, Wang B, Guo P, Gao ZD, Ye YJ, Jiang KW, Wang S. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene. Cell cycle (Georgetown, Tex) 2017;16:224–31.

    Article  CAS  Google Scholar 

  22. Li JH, Zhang SQ, Qiu XG, Zhang SJ, Zheng SH, Zhang DH. Long non-coding RNA NEAT1 promotes malignant progression of thyroid carcinoma by regulating miRNA-214. Int J Oncol. 2017;50:708–16.

    Article  PubMed  CAS  Google Scholar 

  23. Li HM, Yang H, Wen DY, Luo YH, Liang CY, Pan DH, Ma W, Chen G, He Y and Chen JQ. Overexpression of LncRNA HOTAIR is associated with poor prognosis in thyroid carcinoma: a study based on TCGA and GEO data. Hormone Metab Res. 2017;49:388-399.

  24. Zhang R, Hardin H, Huang W, Chen J, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV. MALAT1 long non-coding RNA expression in thyroid tissues: analysis by in situ hybridization and real-time PCR. Endocr Pathol. 2017;28:7–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM, Ma XK, Zhu ZZ, Zhou R. MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1. Biomed Pharmacother. 2016;83:1–7.

    Article  PubMed  CAS  Google Scholar 

  26. Liu L, Yang J, Zhu X, Li D, Lv Z, Zhang X. Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer. FEBS J. 2016;283:2326–39.

    Article  PubMed  CAS  Google Scholar 

  27. Zhou X, Yuan P, Liu Q and Liu Z. LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing microRNA-21. Biomol Ther. 2017;25:490-496.

  28. Wang C, Yan G, Zhang Y, Jia X, Bu P. Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1. Neoplasma 2015;62:541–9.

    Article  PubMed  CAS  Google Scholar 

  29. Xiao L, Rao JN, Cao S, Liu L, Chung HK, Zhang Y, Zhang J, Liu Y, Gorospe M, Wang JY. Long noncoding RNA SPRY4-IT1 regulates intestinal epithelial barrier function by modulating the expression levels of tight junction proteins. Mol Biol Cell. 2016;27:617–26.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Cui F, Wu D, He X, Wang W, Xi J, Wang M. Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition. Tumour Biol. 2016;37:10871–6.

    Article  PubMed  CAS  Google Scholar 

  31. Zhao XL, Zhao ZH, Xu WC, Hou JQ, Du XY. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Int J Clin Exp Pathol. 2015;8:1954–60.

    PubMed  PubMed Central  CAS  Google Scholar 

  32. Xie M, Nie FQ, Sun M, Xia R, Liu YW, Zhou P, De W, Liu XH. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. J Transl Med. 2015;13:250.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Peng W, Wu G, Fan H, Wu J, Feng J. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Tumour Biol. 2015;36:6751–8.

    Article  PubMed  CAS  Google Scholar 

  34. Liu H, Lv Z, Guo E. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Int J Clin Exp Pathol. 2015;8:9140–6.

    PubMed  PubMed Central  CAS  Google Scholar 

  35. Chai S, An W, Guo L, Jiang L, Gao Z, Li S. [Effect of long non-coding RNA SPRY4-IT1 on invasion and migration of A549 cells]. Chin J Lung Cancer 2015;18:487–92.

    Google Scholar 

  36. Riesco-Eizaguirre G, Rodriguez I, De la Vieja A, Costamagna E, Carrasco N, Nistal M, Santisteban P. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res. 2009;69:8317–25.

    Article  PubMed  CAS  Google Scholar 

  37. Ma S, Wang Q, Ma X, Wu L, Guo F, Ji H, Liu F, Zhao Y, Qin G. FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-beta1/Smad signaling pathway. Tumour Biol. 2016;37:989–98.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors conveyed thanks to all laboratory members.

Author information

Author notes

    Authors and Affiliations

    1. School of Food Science, Henan Institute of Science and Technology, Xinxiang, Henan Province, 453000, China

      Haoyu Zhou

    2. Institute of Tropical Agriculture and Forestry, Hainan University, Haikou, Hainan Province, 570228, China

      Zhihua Sun

    3. School of resources and environment, Henan Institute of Science and Technology, Xinxiang, Henan Province, 453000, China

      Songwei Li

    4. ENT & HN Surgery Department, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, 570102, China

      Xiaofeng Wang & Xuejun Zhou

    Authors
    1. Haoyu Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Zhihua Sun
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Songwei Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Xiaofeng Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Xuejun Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Xiaofeng Wang or Xuejun Zhou.

    Ethics declarations

    Conflict of interest

    The authors declare that they have no competing interests.

    Additional information

    Haoyu Zhou and Zhihua Sun contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Zhou, H., Sun, Z., Li, S. et al. LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer. Cancer Gene Ther 25, 39–46 (2018). https://doi.org/10.1038/s41417-017-0003-0

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1038/s41417-017-0003-0

    This article is cited by

    Search

    Advanced search

    Quick links